Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Beijing Continent Pharmaceutical Co, Ltd.

3 clinical trials · 3 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Beijing Continent Pharmaceutical Co, Ltd.

RECRUITINGPhase 1NCT06899815

Preliminary Human Trials of F230 Tablets

F230 is a new Class 1 chemical drug jointly developed by Beijing Contini Pharmaceutical Co., Ltd. for the treatment of pulmonary hypertension (Notification number: 2024LP01242,...

Sponsor: Beijing Continent Pharmaceutical Co, Ltd.Enrolling: 1361 location
Pulmonary Hypertension
RECRUITINGPhase 3NCT05288179

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

This study is a randomized, double-blind, placebo-controlled, multicenter clinical study. The main purpose of this study was to confirm the efficacy and safety of pirfenidone...

Sponsor: Beijing Continent Pharmaceutical Co, Ltd.Enrolling: 2721 location
Pneumoconiosis
RECRUITINGPhase 3NCT05905172

Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

This study is a Phase IIIb extension trial following the "A Randomized, Double-blind, Placebo-controlled, Multicenter, Entecavir-based, Phase III Clinical Trial of Hydronidone...

Sponsor: Beijing Continent Pharmaceutical Co, Ltd.Enrolling: 24820 locations
Liver Fibrosis